The Efficiency and Clinical Adverse Effects of Ambrisentan for Pulmonary Hypertension: Insights from the Meta-Analysis of 493 Patients from 5 Randomized Double-Blind Placebo-Controlled Clinical Trials

2021 ◽  
Vol 11 (03) ◽  
pp. 1437-1448
Author(s):  
奉初 谢
Sign in / Sign up

Export Citation Format

Share Document